In Bio-Rad Laboratories, Inc. v. 10x Genomics Inc., [2019-2255, 2019-2285] (August 3, 2020), the Federal Circuit affirmed the judgment of infringement of U.S. Patent No. 8,889,083 and the entirety of the jury’s damages award, but reversed the district court’s construction … Continue reading Reason for Claim Amendment Was Tangential to Equivalent, Doctrine of Equivalents Applies